JSA Advised The BRLMs In Relation To Senores Pharma’s IPO Worth Rs.582 Cr

Deal Makers

JSA advised Equirus Capital Private Limited, Ambit Private Limited and Nuvama Wealth Management Limited (the book running lead managers) in relation to the initial public offering of equity shares of Senores Pharmaceuticals Limited aggregating to ₹ 5,821.10 million comprising a fresh issue of ₹ 5,000 million and an offer for sale of ₹ 821.10 million by certain selling shareholders of the Company.

The transaction team comprised Lead Partner Arka Mookerjee, Partner Siddhartha Desai, and Associates Govind Roy, Anvita Sinha and Prateek Khandelwal.

Source: JSA’s LinkedIn Page

Anvita Sinha, Arka Mookerjee, Govind Roy, Prateek Khandelwal, Sidhartha Desai

Pharmaceuticals

Capital Markets

The deal reporting on this platform is based on the information received from law firms, and therefore, some details may be missing/incomplete. If your firm has not been credited for this deal, write to us at [email protected] mentioning your firm’s name, lawyers involved (including designation) and client represented.

powered by

powered by

powered by

JSA Advised The BRLMs In Relation To Senores Pharma’s IPO Worth Rs.582 Cr

Deal Makers

Pharmaceuticals

Featured Deals

Closed a deal?

Publish it on TDM

Subscribe to our Newsletter

Legal

Categories

Subscribe to our Newsletter

Newsletter

Contact Us